60,698 Shares in Astera Labs, Inc. $ALAB Bought by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALABFree Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 60,698 shares of the company’s stock, valued at approximately $29,318,000.

Several other hedge funds also recently added to or reduced their stakes in ALAB. BlackRock Inc. acquired a new stake in Astera Labs during the 2nd quarter worth about $6,609,581,000. Atreides Management LP lifted its holdings in shares of Astera Labs by 108.9% in the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after buying an additional 1,754,593 shares during the period. State Street Corp boosted its stake in shares of Astera Labs by 32.5% in the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after buying an additional 760,358 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Astera Labs by 4.5% in the fourth quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock worth $403,598,000 after buying an additional 104,935 shares during the last quarter. Finally, Bank of America Corp DE acquired a new stake in Astera Labs during the second quarter worth about $1,061,791,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, Director Manuel Alba sold 136,974 shares of the company’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the sale, the director owned 1,287,524 shares of the company’s stock, valued at approximately $569,098,483.24. This represents a 9.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of Astera Labs stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief operating officer directly owned 1,119,038 shares in the company, valued at $380,864,583.30. This trade represents a 7.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 419,244 shares of company stock worth $163,135,169. 10.40% of the stock is currently owned by company insiders.

Astera Labs Trading Down 4.8%

ALAB opened at $289.47 on Friday. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48. The firm has a market capitalization of $50.22 billion, a PE ratio of 143.30 and a beta of 3.84. The firm’s 50-day moving average price is $342.38 and its 200 day moving average price is $249.65.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages recently weighed in on ALAB. Weiss Ratings reiterated a “hold (c)” rating on shares of Astera Labs in a research report on Tuesday, August 18th. UBS Group reiterated a “neutral” rating and issued a $425.00 target price on shares of Astera Labs in a research note on Wednesday, August 5th. Citigroup reissued a “buy” rating on shares of Astera Labs in a report on Wednesday, July 29th. Bank of America raised their price objective on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. Finally, Rothschild & Co Redburn assumed coverage on shares of Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $340.53.

Check Out Our Latest Report on Astera Labs

About Astera Labs

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Recommended Stories

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.